Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development

International Journal of Drug Policy

Volumn 27, Issue , 2016, Pages 105-112

  Matheson, Catriona ^a   Thiruvothiyur, Manimekalai ^a   Robertson, Helen ^a   Bond, Christine ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Attitudes; Drug misuse; Naloxone; Opiate replacement treatment; Pharmacy; Training; Workforce

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; CROSS-SECTIONAL STUDY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; MALE; OPIOID-RELATED DISORDERS; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PREVENTIVE HEALTH SERVICE; PROFESSIONAL STANDARD; QUESTIONNAIRE; SCOTLAND; SEX DIFFERENCE; SUBSTANCE-RELATED DISORDERS; TRENDS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; BUPRENORPHINE; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METHADONE; NEEDLE-EXCHANGE PROGRAMS; OPIOID-RELATED DISORDERS; PHARMACISTS; PROFESSIONAL ROLE; SCOTLAND; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES;

EID: 84954368037     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.11.006     Document Type: Article

References (25)

1. Bailey A.M., Wermeling D.P. Naloxone for opioid overdose prevention: Pharmacists' role in community-based practice settings. Annuals of Pharmacotherapy 2014, 48(5):601-606.
2. Barnsdale L., Gordon R., McAuley A. The National Drug-Related Deaths Database (Scotland) report: Analysis of deaths occurring in 2013. Edinburgh 2015.
3. Britten N., Scott J. Community pharmacy services to drug misusers in the south west of England: Results of the 2003-2004 postal survey. International Journal of Pharmacy Practice 2006, 14(4):235-241.
4. Chaar B.B., Hanrahan D.C. Provision of opioid substitution therapy services in Australian pharmacies. Australasian Medical Journal 2011, 4(4):210-216.
5. Edwards P.J., Roberts I., Clarke M.J., Diguiseppi C., Wentz R., Kwan I., et al. Methods to increase response to postal and electronic questionnaires (review). Cochrane Database of Systematic Reviews 2009, 3:1-12.
6. Hagemeier N., Alamian A., Murawski M., Pack R. Factors associated with provision of addiction treatment information by community pharmacists. Journal of substance Abuse Treatment 2015, 52:67-72.
7. ISD Drug Misuse Statistics Scotland 2013 2014, Information and Statistics Division, Scotland, ISD, Scotland, Edinburgh.
8. Lawrinson P., Roche A., Terao H., Le P. Dispensing opioid substitution treatment: Practices, attitudes and intentions of community-based pharmacists. Drug and Alcohol Review 2008, 2:747-753.
9. Matheson C., Bond C.M., Mollison J. Factors associated with community pharmacists' involvement in services for drug misusers. Addiction 1999, 94(9):1349-1359.
10. Matheson C., Bond C.M., Pitcairn J. Community pharmacy services for drug misusers in Scotland: What difference does 5 years make?. Addiction 2002, 97:1405-1411.
11. Matheson C., Bond C.M., Tinelli M. Community Pharmacy harm reduction services for drug misusers: National service delivery and professional attitudes over a decade in Scotland. Journal of Public Health 2007, 29:350-357.
12. Matheson C., Pflanz-Sinclair C., Aucott L., Wilson P., Watson R., Malloy S., et al. Reducing drug related deaths: A pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice. BMC Family Practice 2014, 15(12). http://www.biomedcentral.com/1471-2296/15/12, 10.1186/1471-2296-15-12.
13. McCormick R., Bryant L., Sheridan J., Gonzalez J. New Zealand community pharmacist attitudes toward opioid-dependent clients. Drugs: Education, Prevention, and Policy 2006, 3(6):563-575.
14. Naloxone.org.uk. The Scottish Naloxone Programme website retrieved June 30th 2015 from. http://www.naloxone.org.uk/.
15. NES Pharmaceutical care for substance misuse update. NHS Education for Scotland, Pharmacy 2009.
16. Nielsen S., Dietze P., Dunlop A., Muhleisen P., Lee N., Taylor D. Buprenorphine supply by community pharmacists in Victoria, Australia: Perceptions, experiences and key issues identified. Drug and Alcohol Review 2007, 26(2):143-151.
17. Robertson H., Bond C.M., Matheson C. Community pharmacy services for drug misusers: Measuring national service delivery and the development of professional attitudes over two decades. Family Practice 2015, 32(6):639-645.
18. Scottish Government The road to recovery: A new approach to tackling Scotland's drug problem 2008, Scottish Government, Edinburgh.
19. Scottish Government Hepatitis C Action Plan for Scotland Phase II: May 2008-March 2011. Edinburgh 2008/2.
20. Scottish Government Guidelines for services providing injecting equipment: Best practice guidance for commissioner and injecting equipment provision (IEP) services in Scotland 2010, Scottish Government, Edinburgh.
21. Sheridan J., Manning V., Ridge G., Mayet S., Strang J. Community pharmacies and the provision of opioid substitution services for drug misusers: Changes in activity and attitudes of community pharmacists across England 1995-2005. Addiction 2007, 102(11):1824-1830.
22. Sheridan J., Strang J., Barber N., Glanz A. Role of community pharmacies in relation to HIV and drug misuse: Findings from the 1995 national survey in England and Wales. British Medical Journal 1996, 313:272-274.
23. Uosukainen H., Turunen J., Ilomaki J., Bell S.J. Community pharmacy services for drug misuse: Attitudes and practice of Finnish pharmacists. International Journal of Drug Policy 2014, 25:1139-1142.
24. Winstock A., Lea T., Sheridan J. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria Australia. Addiction 2010, 105:335-342.
25. Zaller N.D., Yokell M.A., Green T.C., Gaggin J., Case P. The feasibility of pharmacy-based naloxone distribution interventions: A qualitative study with injection drug users and pharmacy staff in Rhode Island. Substance Use and Misuse 2013, 48(8):590-599.